Heinrich-Pette-Institut
Records under this name other than patents Heinrich-Pette-Institut holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Heinrich-Pette-Institut
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,898,436 | Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,004,689 | Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,790,870 | Membrane-anchored GP41 peptides that inhibit subsequent HIV viral entry Term ended Term ended Apr 17, 2025 · USPTO record | Term ended | Term ended Apr 17, 2025 | USPTO record |
| US 6,440,730 | Retroviral hybrid vectors pseudotyped with LCMV Term ended Term ended May 11, 2019 · USPTO record | Term ended | Term ended May 11, 2019 | USPTO record |
| US 6,548,301 | Retroviral gene transfer vectors Term ended Term ended May 6, 2019 · USPTO record | Term ended | Term ended May 6, 2019 | USPTO record |
| US 6,589,763 | Retroviral hybrid vectors pseudotyped with LCMV Lapsed on the fee record Ended Jul 8, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2015 | USPTO record |
| US 7,070,992 | Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor Lapsed on the fee record Ended Jul 4, 2010 · USPTO record | Lapsed on the fee record | Ended Jul 4, 2010 | USPTO record |